SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Strobel Gregory A

(Last) (First) (Middle)
100 NORTH POINT CENTER EAST
SUITE 200

(Street)
ALPHARETTA GA 30022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MEDASSETS INC [ MDAS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Revenue Cycle Mgmt
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2013 M 6,064 A $0.00 6,064 D
Common Stock 03/01/2013 S 6,064 D $18.82 (1) 0 D
Common Stock 03/05/2013 M 7,222 A $0.00 7,222 D
Common Stock 03/05/2013 S 7,222 D $19.01 (2) 0 D
Restricted Stock 7,914 (3) D
Restricted Stock 11,871 (4) D
Restricted Stock 11,871 (4) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $15.95 03/01/2013 M 3,618 (5) 03/25/2018 Common Stock 3,618 $0.00 0 D
Stock-Settled Stock Appreciation Rights $14.74 03/01/2013 M 11,933 (6) 01/05/2016 Common Stock 11,933 $0.00 0 D
Stock-Settled Stock Appreciation Rights $15.57 03/01/2013 M 21,998 (7) 03/03/2018 Common Stock 21,998 $0.00 158,002 D
Stock-Settled Stock Appreciation Rights $15.57 03/05/2013 M 53,000 (7) 03/03/2018 Common Stock 53,000 $0.00 105,002 D
Stock-Settled Stock Appreciation Rights $11.58 03/01/2013 M 6,000 (8) 11/09/2018 Common Stock 6,000 $0.00 88,002 D
Stock-Settled Stock Appreciation Rights $11.58 03/05/2013 M 2,000 (8) 11/09/2018 Common Stock 2,000 $0.00 86,002 D
Stock Options (Right to Buy) $22.45 (9) 11/12/2009 Common Stock 50,000 50,000 D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.80 to $18.85, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.99 to $19.08, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
3. The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016.
4. The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013.
5. The reporting person was granted these stock options on March 25, 2008 and are fully vested.
6. The reporting person was granted these SSARs on January 5, 2009 and are fully vested.
7. The reporting person was granted these stock-settled stock appreciation rights (SSARs) on March 3, 2011. The SSARS vest equally (over the course of 60 months) beginning on March 1, 2011 such that 100% of the SSARs will be fully vested on February 1, 2016.
8. The reporting person was granted these SSARs on November 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on November 1, 2011 such that 100% of the SSARs will be fully vested on October 1, 2016.
9. The reporting person was granted these stock options on November 12, 2009. The stock options vest equally (over the course of 60 months) on the first day of each month beginning on November 1, 2009, such that 100% of the options will be fully vested on October 1, 2014.
Remarks:
/s/ Christopher K. Logsdon, Attorney-In-Fact 03/05/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.